Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.7121
H.R.7121: Protecting our Pharmaceutical Supply Chain from China Act of 2022
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced March 17, 2022
- Latest Major Action March 28, 2022
Bill Sponsor
Bill Cosponsors
8 (All Republicans)
Bill Version
- Introduced in House - March 17, 2022
Bill Summary
Protecting our Pharmaceutical Supply Chain from China Act of 2022 This bill requires the federal government to maintain a registry of certain foreign-sourced drugs, prohibits federal health care programs from purchasing drugs containing ingredients manufactured in China, requires drugs to be labeled for country of origin, and offers domestic manufacturing facility tax incentives. The Food and Drug Administration shall maintain (1) a list of...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
March 28, 2022 |
Referred to the Subcommittee on Health.
|
March 18, 2022 |
Referred to the Subcommittee on Health.
|
March 17, 2022 |
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Veterans' Affairs, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
March 17, 2022 |
Introduced in the House by Mike Gallagher (R-Wis.) |